# Mineralys Therapeutics, Inc. (MLYS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Mineralys Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MLYS/mda/fy2025/): filed 2026-03-12; accession 0001933414-26-000056 (https://www.sec.gov/Archives/edgar/data/1933414/000193341426000056/mlys-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/MLYS/mda/fy2024/): filed 2025-02-12; accession 0001933414-25-000009 (https://www.sec.gov/Archives/edgar/data/1933414/000193341425000009/mlys-20241231.htm)
- [FY 2023 MD&A](/company/MLYS/mda/fy2023/): filed 2024-03-21; accession 0001628280-24-012358 (https://www.sec.gov/Archives/edgar/data/1933414/000162828024012358/mlys-20231231.htm)
- [FY 2022 MD&A](/company/MLYS/mda/fy2022/): filed 2023-03-15; accession 0001933414-23-000012 (https://www.sec.gov/Archives/edgar/data/1933414/000193341423000012/mlys2022123110k.htm)

Back to /company/MLYS/